ZYDUSLIFE

has received tentative approval from the USFDA for Empagliflozin and Linagliptin tablets in 10 mg/5 mg and 25 mg/5 mg strengths. This is the company's 429th approval since FY 2003-04. The tablets will be manufactured at the SEZ, Ahmedabad facility.